Bitget Research: Mt.Gox States No Repayments in the Short Term, Crypto Market Stabilizes with Narrow Fluctuations
In the past 24 hours, many new popular tokens and topics have emerged in the market, which are likely to be the next wealth creation opportunities.
Overview
-
Sectors with strong wealth creation effects: RWA sector and Ethereum Layer 2 sector.
-
Top searched tokens and topics: Particle network, Atomicals Protocol, and Celestia.
-
Potential airdrop opportunities: Espresso and Morph.
1. Market Environment
2. Wealth Creation Sectors
2.1 Sector Movements – RWA Sector (ONDO, TRU, and POLYX)
-
Changes in macroeconomic monetary policy: From a macroeconomic perspective, the rise in U.S. 10-Year Treasury Bond Yields supports the fundamentals of the RWA sector. It is essential to monitor subsequent changes in the dollar index, treasury yields, and the cryptocurrency market to adjust trading strategies dynamically.
-
TVL changes in projects: RWA sector projects are generally supported by TVL, making it essential to monitor the changes in this metric. If a project's TVL rises continuously or suddenly, it is usually a signal to buy.
2.2 Sector Movements – Ethereum Layer 2 Sector (ARB, OP, and STRK)
-
Approval of Ethereum ETFs: The market has largely priced in the approval of the Ethereum ETF. Should there be unexpected developments in the ETF approval tomorrow morning, a trend reversal might occur.
-
Development of Layer 2 projects: As a widely used chain ecosystem, the future development of Layer 2 depends on its collaboration with projects and user growth.
2.3 Sectors to Focus on Next — AI Sector
-
OpenAI launched its flagship AI model, capable of real-time audio, visual, and text reasoning processing. The release of the text-to-video model Sora by OpenAI in February drove up valuations across the sector. The launch of GPT-4o highlights the importance of maintaining focus on the AI sector.
-
According to Cointelgraph, tech giant Microsoft is closely monitoring the crypto industry, including ways blockchain technology and artificial intelligence might support each other.
-
TAO: Bittensor is an open-source protocol that powers a blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective.
-
NEAR: Recently, many AI projects within the NEAR ecosystem are in the development or funding stage, positioning NEAR to potentially become a future AI Hub.
3. Top Searches
3.1 Popular DApps
3.2 X (former Twitter)
3.3 Google Search (Global and Regional)
4. Potential Airdrop Opportunities
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
